Who is sponsoring NCT05956184?

NCT05956184 is sponsored by Ankara City Hospital Bilkent.

What drugs are being tested in NCT05956184?

Interventions in NCT05956184: Intrauterine Device Insertion.

What condition does NCT05956184 study?

NCT05956184 studies Intrauterine Device Migration.

Is NCT05956184 still recruiting?

NCT05956184 is currently completed. Last updated 5 September 2023.

Last reviewed 2023-09-05 · How we verify

NCT05956184

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intrauterine Device Insertion and Felt Pain

Completed NA Last updated 5 September 2023

What this trial tests

NA trial testing Intrauterine Device Insertion in Intrauterine Device Migration in 128 participants. Completed in 1 September 2023.

Timeline

13 July 2023

Primary endpoint
1 September 2023

1 September 2023

Quick facts

Lead sponsor	Ankara City Hospital Bilkent
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	128
Start date	13 July 2023
Primary completion	1 September 2023
Estimated completion	1 September 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Intrauterine Device Insertion

Conditions studied

Intrauterine Device Migration — all drugs for Intrauterine Device Migration →

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 18 to 45, female only, with Intrauterine Device Migration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the pain score between the direct method and the conventional method in patients who have undergone copper or hormonal intrauterine devices (IUD) for contraception and to find an answer to the question of which method is better.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of uterine sound on pain perception during intrauterine device insertion: A randomized trial.
Halilzade Mİ, Halilzade İ, Turgay B, Turgay B, et al · · 2025 · PMID 40760565 · DOI 10.1097/md.0000000000043721

Verify or expand the search:

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

NCT07496788 — Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotens · not yet recruiting
NCT07536464 — PEEP Strategies and Mechanical Power in Robotic Surgery · NA · not yet recruiting
NCT07534553 — Mechanical Power Ventilation in RALP · NA · not yet recruiting
NCT07501468 — Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel · NA · not yet recruiting
NCT07502209 — Suprascapular Nerve PRF in Chronic Shoulder Pain · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05956184 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara City Hospital Bilkent
Last refreshed: 5 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05956184.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing